Patents by Inventor Eric Grazzini

Eric Grazzini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ASSAYS
    Publication number: 20080064046
    Abstract: The present invention is directed to assays that can be used to screen for compounds that act as agonists or antagonists or inverse agonists of bovine adrenal medulla docosapeptide (BAM-22P). The assays are based upon the binding of BAM-22P to the rat and human DRR receptors.
    Type: Application
    Filed: August 14, 2007
    Publication date: March 13, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Sultan Ahmad, Eric Grazzini, Thierry Groblewski, Paola Lembo, Ralf Schmidt
  • Assays to screen for compounds that bind the dorsal root receptor
    Patent number: 7270965
    Abstract: The present invention is directed to assays that can be used to screen for compounds that act as agonists or antagonists or inverse agonists of bovine adrenal medulla docosapeptide (BAM-22P). The assays are based upon the binding of BAM-22P to the rat and human DRR receptors.
    Type: Grant
    Filed: October 16, 2001
    Date of Patent: September 18, 2007
    Assignee: AstraZeneca AB
    Inventors: Sultan Ahmad, Eric Grazzini, Thierry Groblewski, Paolo Lembo, Ralf Schmidt
  • Method of assaying for agonists or antagonist of Dynorphin A binding to the MAS receptor
    Patent number: 7078177
    Abstract: The present invention is directed to assays that can be used to screen for compounds that act as agonists or antagonists or inverse agonists of Dynorphin A and its analogues. The assays are based upon the binding of Dynorphin A and its analogues to the rat and human MAS receptors.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: July 18, 2006
    Assignee: AstraZeneca AB
    Inventors: Sultan Ahmad, Eric Grazzini, Paola Lembo
  • Assays
    Publication number: 20050059575
    Abstract: The present invention is directed to assays that can be used to screen for compounds that act as agonists or antagonists or inverse agonists of bovine adrenal medulla docosapeptide (BAM-22P). The assays are based upon the binding of BAM-22P to the rat and human DRR receptors.
    Type: Application
    Filed: October 16, 2001
    Publication date: March 17, 2005
    Inventors: Sultan Ahmad, Eric Grazzini, Thierry Groblewski, Paola Lembo, Ralf Schmidt
  • Method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor
    Publication number: 20040171080
    Abstract: The present invention is directed to assays that can be used to screen for compounds that act as agonists or antagonists or inverse agonists of Dynorphin A and its analogues. The assays are based upon the binding of Dynorphin A and its analogues to the rat and human MAS receptors.
    Type: Application
    Filed: June 20, 2003
    Publication date: September 2, 2004
    Inventors: Sultan Ahmad, Eric Grazzini, Paola Lembo